Cargando…

A Review of the Dermatological Complications of Giant Cell Arteritis

Giant cell arteritis (GCA) is characterized by granulomatous inflammation of large and medium-sized vessels. It is the most common vasculitis among elderly people in Europe and North America. GCA usually presents with ischemic cranial manifestations such as headache, scalp tenderness, visual manifes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prieto-Peña, Diana, Castañeda, Santos, Atienza-Mateo, Belén, Blanco, Ricardo, González-Gay, Miguel Ángel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008160/ https://www.ncbi.nlm.nih.gov/pubmed/33790612 http://dx.doi.org/10.2147/CCID.S284795

Ejemplares similares

Imaging Tests in the Early Diagnosis of Giant Cell Arteritis
por: Prieto-Peña, Diana, et al.
Publicado: (2021)

Advances in the Treatment of Giant Cell Arteritis
por: Castañeda, Santos, et al.
Publicado: (2022)

Cranial and extracranial giant cell arteritis do not have different HLA-DRB1 and HLA-B association in Caucasian individuals
por: Prieto-Peña, Diana, et al.
Publicado: (2021)

Moderate and High Disease Activity Predicts the Development of Carotid Plaque in Rheumatoid Arthritis Patients without Classic Cardiovascular Risk Factors: Six Years Follow-Up Study
por: Ferraz-Amaro, Iván, et al.
Publicado: (2021)

Genetic epidemiology: Giant cell arteritis and polymyalgia rheumatica
por: Gonzalez-Gay, Miguel A
Publicado: (2001)

Giant cell arteritis: is the clinical spectrum of the disease changing?
por: González-Gay, Miguel Á., et al.
Publicado: (2019)

The Performance of Vascular Age in the Assessment of Cardiovascular Risk of Patients with Rheumatoid Arthritis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2020)

Misperception of the Cardiovascular Risk in Patients with Rheumatoid Arthritis
por: Alonso-Molero, Jéssica, et al.
Publicado: (2020)

Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients
por: Loricera, Javier, et al.
Publicado: (2022)

Association between IL-18 gene polymorphisms and biopsy-proven giant cell arteritis
por: Palomino-Morales, Rogelio J, et al.
Publicado: (2010)

Correction: Ferraz-Amaro et al. SCORE2 Assessment in The Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis. Diagnostics 2021, 11, 2363
por: Ferraz-Amaro, Iván, et al.
Publicado: (2022)

SCORE2 Assessment in the Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2021)

Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review
por: Prieto-Peña, Diana, et al.
Publicado: (2021)

Rare Ischemic Complications of Giant Cell Arteritis: Case Series and Literature Review
por: Jalaledin, Darya S., et al.
Publicado: (2022)

The Number of Traditional Cardiovascular Risk Factors Is Independently Correlated with Disease Activity in Patients with Psoriatic Arthritis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2020)

Giant Cell Arteritis
por: Coulier, Bruno, et al.
Publicado: (2018)

Ocular Complications of Giant Cell Arteritis: An Acute Therapeutic Emergency
por: Héron, Emmanuel, et al.
Publicado: (2022)

Giant Cell Arteritis versus Takayasu Arteritis: An Update
por: Stamatis, Pavlos
Publicado: (2020)

Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review
por: Atienza-Mateo, Belén, et al.
Publicado: (2020)

Giant cell arteritis complicated by acute pancreatitis: a case report
por: Seneviratne, Deepthi Renuka, et al.
Publicado: (2008)

Temporal swelling: beyond giant cell arteritis
por: Martins-Martinho, Joana, et al.
Publicado: (2023)

Treatment of Giant Cell Arteritis and Takayasu Arteritis—Current and Future
por: Hellmich, B., et al.
Publicado: (2020)

Specific microbiome profile in Takayasu’s arteritis and giant cell arteritis
por: Desbois, Anne Claire, et al.
Publicado: (2021)

Validity of the EULAR recommendations on the use of ultrasound in the diagnosis of giant cell arteritis
por: Fernández-Fernández, Elisa, et al.
Publicado: (2022)

An Updated Review of Cardiovascular Events in Giant Cell Arteritis
por: de Boysson, Hubert, et al.
Publicado: (2022)

Giant cell arteritis: reviewing the advancing diagnostics and management
por: Bilton, Edward J., et al.
Publicado: (2023)

Giant Cells in Dermatology
por: Gupta, Gaurang, et al.
Publicado: (2014)

Doppler ultrasound and giant cell arteritis
por: Suelves, Ana Marina, et al.
Publicado: (2010)

An Unusual Presentation of Giant Cell Arteritis
por: Prabhavalkar, Siddhesh, et al.
Publicado: (2012)

Biologic Therapies for Giant Cell Arteritis
por: Harrington, Robert, et al.
Publicado: (2021)

Giant Cell Arteritis and Cardiac Comorbidity
por: Arias, Magela, et al.
Publicado: (2021)

Treatment failure in giant cell arteritis
por: Unizony, Sebastian H, et al.
Publicado: (2021)

Treatment of Giant Cell Arteritis (GCA)
por: Régent, Alexis, et al.
Publicado: (2022)

An Unusual Case of Giant Cell Arteritis
por: Goyal, Nitasha, et al.
Publicado: (2022)

Evolution of ultrasound in giant cell arteritis
por: Kirby, Colm, et al.
Publicado: (2022)

Cardiovascular lesions in giant cell arteritis
por: Dzhus, Marta, et al.
Publicado: (2022)

Mycophenolate mofetil in giant cell arteritis
por: Pankow, Anne, et al.
Publicado: (2023)

A TNFSF13B functional variant is not involved in systemic sclerosis and giant cell arteritis susceptibility
por: González-Serna, David, et al.
Publicado: (2018)

Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care
por: Molina-Collada, Juan, et al.
Publicado: (2023)

Clinical Images: Pulmonary Arteritis in Clinically Occult Aneurysmal Giant Cell Arteritis
por: Johnson, Victoria L, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_peik6mf68qgur80thr0bl3sns8